1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 265 F.Supp.2d
  5. 265 F.Supp.2d 213 (2003)
 

ASTRAZENECA AB v. MYLAN LABORATORIES, INC.

Nos. 00 Civ. 6749(BSJ), 00 Civ. 7598(BSJ). M-21-81, MDL 1291.

265 F.Supp.2d 213 (2003)

ASTRAZENECA AB, et al., Plaintiffs, v. MYLAN LABORATORIES, INC. and Mylan Pharmaceuticals, Inc. Defendants. Astra Aktiebolag, et al., Plaintiffs, v. Eon Labs Manufacturing, Inc., Defendant. In re Omeprazole Patent Litigation

United States District Court, S.D. New York.

May 21, 2003.

OPINION AND ORDER

JONES, District Judge.

Plaintiffs, AstraZeneca AB, Aktiebolaget Hassle, KBI-E-Inc, KBI Inc., and AstraZeneca, LP, (collectively "Astra"), seek leave to amend their complaint against defendants Mylan Laboratories Inc., and Mylan Pharmaceuticals, Inc. (collectively "Mylan") to add Esteve Quimica S.A. ("Esteve Quimica") and Laboratories Dr. Esteve S.A ("Laboratories Dr. Esteve"), (collectively "Esteve") as defendants accused of inducing...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases